Interaction of HLA-DRB1*03 and smoking for the development of anti-Jo-1 antibodies in adult idiopathic inflammatory myopathies: a European-wide case study
Open Access
- 20 December 2011
- journal article
- research article
- Published by BMJ in Annals Of The Rheumatic Diseases
- Vol. 71 (6), 961-965
- https://doi.org/10.1136/annrheumdis-2011-200182
Abstract
Objectives HLA-DRB1*03 is strongly associated with anti-Jo-1-positive idiopathic inflammatory myopathies (IIM) and there is now increasing evidence that Jo-1 antigen is preferentially expressed in lung tissue. This study examined whether smoking was associated with the development of anti-Jo-1 antibodies in HLA-DRB1*03-positive IIM. Methods IIM cases were selected with concurrent information regarding HLA-DRB1 status, smoking history and anti-Jo-1 antibody status. DNA was genotyped at DRB1 using a commercial sequence-specific oligonucleotide kit. Anti-Jo-1 antibody status was established using a line blot assay or immunoprecipitation. Results 557 Caucasian IIM patients were recruited from Hungary (181), UK (99), Sweden (94) and Czech Republic (183). Smoking frequency was increased in anti-Jo-1-positive IIM cases, and reached statistical significance in Hungarian IIM (45% Jo-1-positive vs 17% Jo-1-negative, OR 3.94, 95% CI 1.53 to 9.89, p<0.0001). A strong association between HLA-DRB1*03 and anti-Jo-1 status was observed across all four cohorts (DRB1*03 frequency: 74% Jo-1-positive vs 35% Jo-1-negative, OR 5.55, 95% CI 3.42 to 9.14, p<0.0001). The frequency of HLA-DRB1*03 was increased in smokers. The frequency of anti-Jo-1 was increased in DRB1*03-positive smokers vs DRB1*03-negative non-smokers (42% vs 8%, OR 7.75, 95% CI 4.21 to 14.28, p<0.0001) and DRB1*03-positive non-smokers (42% vs 31%, p=0.08). In DRB1*03-negative patients, anti-Jo-1 status between smokers and non-smokers was not significantly different. No significant interaction was noted between smoking and DRB1*03 status using anti-Jo-1 as the outcome measure. Conclusion Smoking appears to be associated with an increased risk of possession of anti-Jo-1 in HLA-DRB1*03-positive IIM cases. The authors hypothesise that an interaction between HLA-DRB1*03 and smoking may prime the development of anti-Jo-1 antibodies.This publication has 31 references indexed in Scilit:
- Immunogenetic risk and protective factors for juvenile dermatomyositis in CaucasiansArthritis & Rheumatism, 2006
- In adult onset myositis, the presence of interstitial lung disease and myositis specific/associated antibodies are governed by HLA class II haplotype, rather than by myositis subtypeArthritis Research & Therapy, 2006
- Immunogenetic Risk and Protective Factors for the Idiopathic Inflammatory MyopathiesMedicine, 2005
- The role of genetic factors in autoimmune disease: implications for environmental research.Environmental Health Perspectives, 1999
- Genetic risk and protective factors for idiopathic inflammatory myopathy in Koreans and American Whites: A tale of two lociArthritis & Rheumatism, 1999
- The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseasesImmunological Reviews, 1999
- Immunogenetic studies in families of children with juvenile dermatomyositis.1998
- Clinical, serologic, and immunogenetic features of familial idiopathic inflammatory myopathyArthritis & Rheumatism, 1998
- Clinical, serologic, and immunogenetic features in polish patients with idiopathic inflammatory myopathiesArthritis & Rheumatism, 1997
- Interrelationship of major histocompatibility complex class II alleles and autoantibodies in four ethnic groups with various forms of myositisArthritis & Rheumatism, 1996